Publication of Circular

RNS Number : 1599J
Dechra Pharmaceuticals PLC
11 July 2013
 



 

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

 

Publication of shareholder circular in relation to the proposed disposal of the Services Segment

 

 

London, 11 July 2013

 

For immediate release

 

 

The Board of Dechra announced yesterday the proposed sale of the Services Segment (the "Disposal"). In view of its size, the Disposal is conditional, inter alia, upon the approval of Dechra Shareholders, and the Company confirms that a circular containing further details of the Disposal and a Notice convening a General Meeting of the Company to be held at the Company's offices at 24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich CW9 7UA at 12.00 noon on 29 July 2013, has today been published and posted to Dechra Shareholders.

 

In compliance with LR 9.6.1R and LR 9.6.3R, the Company confirms that the Circular and the Form of Proxy have also been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/nsm and on the Company's website at: http://www.dechra.com/.

 

 

Enquiries:

Ian Page, Chief Executive

Fiona Tooley, Director

Anne-Francoise Nesmes, Chief Financial Officer

TooleyStreet Communications

Dechra Pharmaceuticals PLC

Telephone: +44 (0) 121 309 0099

Telephone: + 44 (0) 1606 814730

Mobile: +44 (0) 778 570 3523 (FT)

www.dechra.com

Ticker: Full Listing (Pharmaceuticals): DPH

 

 

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASXFFSSDEFF
UK 100

Latest directors dealings